| The challenges of COVID-19 for community pharmacists and opportunities for the future JC Hayden, R Parkin Irish journal of psychological medicine 37 (3), 198-203, 2020 | 147 | 2020 |
| Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial AJ Bell, R Belloma, A Bersten, R Boots, P Bristow, M Chapman, ... University Of Tasmania, 2000 | 108* | 2000 |
| Role of IL-35 in sublingual allergen immunotherapy MH Shamji, JA Layhadi, D Achkova, L Kouser, A Perera-Webb, ... Journal of Allergy and Clinical Immunology 143 (3), 1131-1142. e4, 2019 | 106 | 2019 |
| Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy MH Shamji, D Larson, A Eifan, GW Scadding, T Qin, K Lawson, ML Sever, ... Journal of Allergy and Clinical Immunology 148 (4), 1061-1071. e11, 2021 | 61 | 2021 |
| Passive prophylactic administration with a single dose of Anti–Fel d 1 monoclonal antibodies REGN1908–1909 in cat allergen–induced allergic rhinitis: A randomized, double-blind … MH Shamji, I Singh, JA Layhadi, C Ito, A Karamani, L Kouser, H Sharif, ... American Journal of Respiratory and Critical Care Medicine 204 (1), 23-33, 2021 | 48 | 2021 |
| Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy H Sharif, S Acharya, GKR Dhondalay, G Varricchi, S Krasner-Macleod, ... Journal of Allergy and Clinical Immunology 147 (2), 663-676, 2021 | 48 | 2021 |
| Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: a randomized trial JR Konradsen, J Grundström, L Hellkvist, TAT Tran, N Andersson, ... Journal of Allergy and Clinical Immunology 145 (3), 1005-1007. e7, 2020 | 43 | 2020 |
| Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: a randomized, double-blind, placebo-controlled trial H Sharif, I Singh, L Kouser, R Mösges, MA Bonny, A Karamani, RV Parkin, ... Journal of Allergy and Clinical Immunology 144 (3), 738-749, 2019 | 42 | 2019 |
| A recombinant fragment of human surfactant protein D suppresses basophil activation and T-helper type 2 and B-cell responses in grass pollen–induced allergic inflammation AS Qaseem, I Singh, AA Pathan, JA Layhadi, R Parkin, F Alexandra, ... American journal of respiratory and critical care medicine 196 (12), 1526-1534, 2017 | 20 | 2017 |
| A systematic review of interventions to enhance adherence and persistence with ADHD pharmacotherapy R Parkin, F Mc Nicholas, JC Hayden Journal of Psychiatric Research 152, 201-218, 2022 | 8 | 2022 |
| Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy MC Altman, RM Segnitz, D Larson, ND Jayavelu, MT Smith, S Patel, ... Journal of Allergy and Clinical Immunology 152 (5), 1247-1260, 2023 | 3 | 2023 |
| Single-cell RNA sequencing identifies precise tolerogenic cellular and molecular pathways induced by depigmented-polymerized grass pollen allergen extract JA Layhadi, R Moya, TJ Tan, MM Lenormand, H Sharif, RV Parkin, ... Journal of Allergy and Clinical Immunology 151 (5), 1357-1370. e9, 2023 | 3 | 2023 |
| Grass pollen immunotherapy alters chromatin landscape in circulating T follicular and regulatory cells H Sharif, S Acharya, GKR Dhondalay, G Varricchi, S Krasner-Macleod, ... J Allergy Clin Immunol, 2020 | 2 | 2020 |
| Basophil activation during-but not prior to-IgE-mediated allergic reactions to peanut correlates with symptom severity PJ Turner, M Ruiz-Garcia, R Parkin, O McMahon, A Clark, RJ Boyle, ... Allergy 70, 48-48, 2015 | 2 | 2015 |
| Hydrolyzed Lolium perenne peptide fragments administered subcutaneously to hay fever patients induce allergen-specific IgG (4) and blocking antibodies after two or more weeks … MH Shamji, EM Kasche, G Zadoyan, A Astvatsourov, SR Durham, ... Allergy 70, 631-633, 2015 | 2 | 2015 |
| Nasal allergen‐neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with … I Eguiluz‐Gracia, RV Parkin, JA Layhadi, E Palmer, X Meng, R Zhu, ... Allergy, 2024 | 1 | 2024 |
| Single-cell RNA-Seq identifies precise tolerogenic cellular and molecular pathways induced by depigmented-polymerized grass pollen allergen extract J Layhadi, RM Lobo, TT Ju, M Burki, HHASH Awg, R Parkin, G Vila-Nadal, ... Journal of Allergy and Clinical Immunology 151 (2), AB167, 2023 | 1 | 2023 |
| Surfactant protein-D (SP-D): a potential therapeutic target for seasonal allergic rhinitis I Singh, A Qaseem, A Pathan, R Parkin, U Kishore, SR Durham, ... Journal of Allergy and Clinical Immunology 139 (2), AB84, 2017 | 1 | 2017 |
| Immunogenicity evaluation of subcutaneous administration of peptide hydrolysate from Lolium perenne (gpASIT plus TM) in combination with bacterial HSP70 (DnaK) in patients with … MH Shamji, J Ceuppens, P Hellings, SR Durham, J Duchateau, T Legon, ... Allergy 69, 31-31, 2014 | 1 | 2014 |
| Induction of Allergen-Neutralizing IgG4 and IgA Blocking Antibodies Following Subcutaneous Immunotherapy with Mannan-Conjugated Birch Pollen Allergoid A Devine, E Raskopf, R Parkin, E Palmer, L Radtke, M Casanovas, ... Journal of Allergy and Clinical Immunology 149 (2), AB72, 2022 | | 2022 |
